Search Results - "Mekala, Armugam"

Refine Results
  1. 1

    Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis by Tatomir, Alexandru, Anselmo, Freidrich, Boodhoo, Dallas, Chen, Hegang, Mekala, Armugam P, Nguyen, Vinh, Cuevas, Jacob, Rus, Violeta, Rus, Horea

    Published in Frontiers in immunology (27-06-2024)
    “…Regular assessment of disease activity in relapsing-remitting multiple sclerosis (RRMS) is required to optimize clinical outcomes. Biomarkers can be a valuable…”
    Get full text
    Journal Article
  2. 2

    JNK and phosphorylated Bcl-2 predict multiple sclerosis clinical activity and glatiramer acetate therapeutic response by Anselmo, Freidrich, Tatomir, Alexandru, Boodhoo, Dallas, Mekala, Armugam P., Nguyen, Vinh, Rus, Violeta, Rus, Horea

    Published in Clinical immunology (Orlando, Fla.) (01-01-2020)
    “…In this study, we investigated the role of JNK and phospho-Bcl-2 as possible biomarkers of multiple sclerosis (MS) relapse and of glatiramer acetate (GA)…”
    Get full text
    Journal Article
  3. 3

    The role of complement activation in atherogenesis: the first 40 years by Vlaicu, Sonia I., Tatomir, Alexandru, Rus, Violeta, Mekala, Armugam P., Mircea, Petru A., Niculescu, Florin, Rus, Horea

    Published in Immunologic research (01-02-2016)
    “…The pathogenesis of atherosclerotic inflammation is a multi-step process defined by the interweaving of excess modified lipid particles, monocyte-macrophages…”
    Get full text
    Journal Article
  4. 4

    Role of SIRT1 in autoimmune demyelination and neurodegeneration by Martin, Alvaro, Tegla, Cosmin A., Cudrici, Cornelia D., Kruszewski, Adam M., Azimzadeh, Philippe, Boodhoo, Dallas, Mekala, Armugam P., Rus, Violeta, Rus, Horea

    Published in Immunologic research (01-03-2015)
    “…Multiple sclerosis (MS) is a demyelinating disease characterized by chronic inflammation of the central nervous system, in which many factors can act together…”
    Get full text
    Journal Article
  5. 5

    RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis by Rus, Violeta, Nguyen, Vinh, Tatomir, Alexandru, Lees, Jason R, Mekala, Armugam P, Boodhoo, Dallas, Tegla, Cosmin A, Luzina, Irina G, Antony, Paul A, Cudrici, Cornelia D, Badea, Tudor C, Rus, Horea G

    Published in The Journal of immunology (1950) (15-05-2017)
    “…Th17 cells play a critical role in autoimmune diseases, including multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. Response…”
    Get full text
    Journal Article
  6. 6

    A Flare-up of Systemic Lupus Erythematosus with Unusual Enteric Predominance by Ronen, Joshua A, Mekala, Armugam, Wiechmann, Catherine, Mungara, Sai

    Published in Curēus (Palo Alto, CA) (21-02-2020)
    “…Enteritis associated with systemic lupus erythematosus (SLE) is a rare and unusual manifestation of the gastrointestinal (GI) consequences of SLE itself…”
    Get full text
    Journal Article
  7. 7

    RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune Encephalomyelitis by Tatomir, Alexandru, Beltrand, Austin, Nguyen, Vinh, Boodhoo, Dallas, Mekala, Armugam, Cudrici, Cornelia, Badea, Tudor C, Muresanu, Dafin F, Rus, Violeta, Rus, Horea

    Published in Frontiers in immunology (25-01-2021)
    “…Astrocytes are increasingly recognized as critical contributors to multiple sclerosis pathogenesis. We have previously shown that lack of Response Gene to…”
    Get full text
    Journal Article
  8. 8

    Amantadine-Induced Cardiac Arrest in a Patient With COVID-19 by Bakhati, Bibek, Sibi, Victoria M, Mekala, Armugam P, Ronen, Joshua A, Mungara, Sai S

    Published in Curēus (Palo Alto, CA) (17-01-2022)
    “…Amantadine, which is known for its antiviral activity, is presently used as therapy for Parkinson's disease. Adverse effects, such as cardiac arrhythmias, have…”
    Get full text
    Journal Article
  9. 9

    RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis by Tatomir, Alexandru, Tegla, Cosmin A., Martin, Alvaro, Boodhoo, Dallas, Nguyen, Vinh, Sugarman, Adam J., Mekala, Armugam, Anselmo, Freidrich, Talpos-Caia, Anamaria, Cudrici, Cornelia, Badea, Tudor C., Rus, Violeta, Rus, Horea

    Published in Immunologic research (01-08-2018)
    “…Extracellular matrix (ECM) deposition in active demyelinating multiple sclerosis (MS) lesions may impede axonal regeneration and can modify immune reactions…”
    Get full text
    Journal Article
  10. 10
  11. 11

    RGC-32 is a novel regulator of the T-lymphocyte cell cycle by Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vinh, Danoff, Jacob, Kruszewski, Adam M., Boodhoo, Dallas, Mekala, Armugam P., Vlaicu, Sonia I., Chen, Ching, Rus, Violeta, Badea, Tudor C., Rus, Horea

    Published in Experimental and molecular pathology (01-06-2015)
    “…We have previously shown that RGC-32 is involved in cell cycle regulation in vitro. To define the in vivo role of RGC-32, we generated RGC-32 knockout mice…”
    Get full text
    Journal Article
  12. 12

    What Is Uncommon Can Be Critical: A Case of Quinolone-Induced Acute Liver Failure by Bakhati, Bibek, Sibi, Victoria M, Mekala, Armugam P, Ronen, Joshua A, Mungara, Sai

    Published in Curēus (Palo Alto, CA) (30-04-2021)
    “…Many drugs are known to potentially cause liver injury; however, only a few reports investigate the association between levofloxacin and acute liver failure…”
    Get full text
    Journal Article
  13. 13

    Heroin Relapse "Strikes a Nerve": A Rare Case of Drug-Induced Acute Myelopathy by Sidhu, Mandeep K, Mekala, Armugam P, Ronen, Joshua A, Hamdan, Ahmad, Mungara, Sai S

    Published in Curēus (Palo Alto, CA) (23-06-2021)
    “…Opioid addiction is a major public health problem. Through a commitment to individualized treatment plans meant to help patients meet personal goals,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    RGC-32 enhances experimental autoimmune encephalomyelitis by promoting Il-17 and GM-CSF production by Rus, Violeta, Nguyen, Vinh, Tatomir, Alexandru, Mekala, Armugam Prasad, Boodhoo, Dallas, Rus, Horea G

    Published in The Journal of immunology (1950) (01-05-2017)
    “…Response Gene to Complement (RGC)-32 is an intracytoplasmatic protein expressed in a variety of cells in response to sublytic complement activation, TGF-β and…”
    Get full text
    Journal Article
  16. 16

    Response Gene to Complement-32 promotes Th17 cell differentiation through TGF-β dependent and independent mechanisms by Rus, Violeta, Nguyen, Vinh, Tatomir, Alexandru, Mekala, Armugam Prasad, Rus, Horea G

    Published in The Journal of immunology (1950) (01-05-2016)
    “…Response Gene to Complement (RGC)-32 is an intracytoplasmatic protein expressed in a variety of cells in response to sublytic complement activation, TGF-β and…”
    Get full text
    Journal Article
  17. 17

    RGC-32 enhances suboptimal CD8 cytotoxic T cell effector function in acute graft versus host disease and promotes lupus-like disease in chronic graft versus host disease (THER2P.965) by Rus, Violeta, Nguyen, Vinh, Badea, Tudor, Cudrici, Cornelia, Tegla, Cosmin, Mekala, Armugam, Rus, Horea

    Published in The Journal of immunology (1950) (01-05-2015)
    “…Response Gene to Complement (RGC)-32 is an intracytoplasmatic protein expressed in a variety of cells in response to sublytic complement activation, TGFb and…”
    Get full text
    Journal Article
  18. 18

    RGC-32 regulates TGF-β extracellular matrix production in multiple sclerosis by Tatomir, Alexandru, Tegla, Cosmin A, Cudrici, Cornelia D, Boodhoo, Dallas, Martin, Alvaro, Mekala, Armugam, Rus, Violeta, Badea, Tudor C, Rus, Horea

    Published in The Journal of immunology (1950) (01-05-2016)
    “…Extracellular matrix (ECM) deposition in demyelinating multiple sclerosis (MS) lesions may impede axonal regeneration and modify immune responses. RGC-32 plays…”
    Get full text
    Journal Article
  19. 19
  20. 20